DPP-4 inhibitor combined with insulin

This page covers all DPP-4 inhibitor combined with insulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DPP-4 (dipeptidyl peptidase-4).

Targets

DPP-4 (dipeptidyl peptidase-4)

Phase 3 pipeline (1)

• Alogliptin and insulin · Takeda · Diabetes
  Alogliptin inhibits dipeptidyl peptidase-4 (DPP-4) to increase incretin levels and improve glucose control, while insulin provides exogenous glucose-lowering activity.

Patent intelligence

• dpp 4 inhibitor combined with insulin patent landscape — aggregated cliff calendar, attackable patents, originator estates